Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis
Completed · Not applicable
Conditions studied: Cystic Fibrosis
In brief
The investigators know that adherence to medications in children with cystic fibrosis (CF) is poor. Forgetfulness has often been reported as a barrier to adherence by both CF patients and their parents. Many of the investigators patients also report being motivated by the results of their lung function studies (PFTs) to stay adherent to their medications. In this study, the investigators would like to see if providing medication reminders and allowing patients to measure their lung function at home will lead to better adherence. This will be a pilot study to determine the feasibility of providing such as a device to children with CF.
Key facts
- Study ID
- NCT02301377
- Run by
- University of Michigan
- People needed
- 5
- Starts
- 2014-11-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2015-07-16
Who can join
Age: 10 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 10-21 years
- Confirmed diagnosis of cystic fibrosis (CF) either by a sweat chloride ≥ 60mEq/L or the presence of two disease-causing mutations
- Patients must be clinically stable with at least 1 month from their last hospitalization or use of oral antibiotics for a pulmonary exacerbation
- Signed informed consent from the patient and/or from the parent/legal guardian, if younger than 18 years.
You may not qualify if…
- Age less than 10 years or greater than 21 years
- Clinically unstable
Where it is running
- University of Michigan — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.